Literature DB >> 24954262

TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction.

Vahe Badalyan1, Robert Thompson2, Kezia Addo2, Lee A Borthwick3, Andrew J Fisher3, Tatiana Ort4, Timothy G Myers5, Thomas A Wynn2, Thirumalai R Ramalingam6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24954262      PMCID： PMC4186904          DOI： 10.1016/j.jaci.2014.05.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.

Authors:  Stefan Fichtner-Feigl; Warren Strober; Koji Kawakami; Raj K Puri; Atsushi Kitani
Journal:  Nat Med       Date:  2005-12-04       Impact factor: 53.440

2.  Lebrikizumab treatment in adults with asthma.

Authors:  Jonathan Corren; Robert F Lemanske; Nicola A Hanania; Phillip E Korenblat; Merdad V Parsey; Joseph R Arron; Jeffrey M Harris; Heleen Scheerens; Lawren C Wu; Zheng Su; Sofia Mosesova; Mark D Eisner; Sean P Bohen; John G Matthews
Journal:  N Engl J Med       Date:  2011-08-03       Impact factor: 91.245

3.  Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma.

Authors:  S F Seys; M Grabowski; W Adriaensen; A Decraene; E Dilissen; J A Vanoirbeek; L J Dupont; J L Ceuppens; D M A Bullens
Journal:  Clin Exp Allergy       Date:  2013-09       Impact factor: 5.018

Review 4.  IL-13 effector functions.

Authors:  Thomas A Wynn
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

5.  TNF-alpha and IL-4 regulate expression of IL-13 receptor alpha2 on human fibroblasts.

Authors:  Mamoru Yoshikawa; Toshiharu Nakajima; Toshiharu Tsukidate; Kenji Matsumoto; Makoto Iida; Nobuyoshi Otori; Shin-ichi Haruna; Hiroshi Moriyama; Hirohisa Saito
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

6.  The innate antiviral response upregulates IL-13 receptor α2 in bronchial fibroblasts.

Authors:  Gemma Campbell-Harding; Hannah Sawkins; Nicole Bedke; Stephen T Holgate; Donna E Davies; Allison-Lynn Andrews
Journal:  J Allergy Clin Immunol       Date:  2012-10-12       Impact factor: 10.793

7.  Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain.

Authors:  Thirumalai R Ramalingam; John T Pesce; Faruk Sheikh; Allen W Cheever; Margaret M Mentink-Kane; Mark S Wilson; Sean Stevens; David M Valenzuela; Andrew J Murphy; George D Yancopoulos; Joseph F Urban; Raymond P Donnelly; Thomas A Wynn
Journal:  Nat Immunol       Date:  2007-12-09       Impact factor: 25.606

Review 8.  IL-13 receptor isoforms: breaking through the complexity.

Authors:  Yasuhiro Tabata; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

9.  A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects.

Authors:  M O'Toole; H Legault; R Ramsey; T A Wynn; M T Kasaian
Journal:  Clin Exp Allergy       Date:  2008-02-25       Impact factor: 5.018

10.  Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production.

Authors:  Dawn C Newcomb; Madison G Boswell; Weisong Zhou; Matthew M Huckabee; Kasia Goleniewska; Carla M Sevin; Gurjit K Khurana Hershey; Jay K Kolls; R Stokes Peebles
Journal:  J Allergy Clin Immunol       Date:  2011-01-13       Impact factor: 10.793
  10 in total
  12 in total

1.  Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma.

Authors:  Kevin M Hart; David F Choy; Peter Bradding; Thomas A Wynn; Joseph R Arron
Journal:  Ann Transl Med       Date:  2017-02

2.  Commentary: IL-4 and IL-13 receptors and signaling.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Cytokine       Date:  2015-07-14       Impact factor: 3.861

Review 3.  Type 2 cytokines: mechanisms and therapeutic strategies.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2015-04-17       Impact factor: 53.106

Review 4.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

5.  Interleukin-13 in Asthma and Other Eosinophilic Disorders.

Authors:  Emma Doran; Fang Cai; Cécile T J Holweg; Kit Wong; Jochen Brumm; Joseph R Arron
Journal:  Front Med (Lausanne)       Date:  2017-09-19

6.  Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice.

Authors:  José L Reyes; Danielle T Vannan; Tina Vo; Aliya Gulamhusein; Paul L Beck; Raylene A Reimer; Bertus Eksteen
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

7.  Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease.

Authors:  Bram Verstockt; Clémentine Perrier; Gert De Hertogh; Jonathan Cremer; Brecht Creyns; Gert Van Assche; Marc Ferrante; Jan L Ceuppens; Séverine Vermeire; Christine Breynaert
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

8.  Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease.

Authors:  Erik P Karmele; Trisha S Pasricha; Thirumalai R Ramalingam; Robert W Thompson; Richard L Gieseck; Kayla J Knilans; Martin Hegen; Mark Farmer; Fang Jin; Aaron Kleinman; David A Hinds; Thiago Almeida Pereira; Rafael de Queiroz Prado; Nan Bing; Lioudmila Tchistiakova; Marion T Kasaian; Thomas A Wynn; Kevin M Vannella
Journal:  Mucosal Immunol       Date:  2019-07-15       Impact factor: 7.313

9.  A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis.

Authors:  Yannick van Sleen; William F Jiemy; Sarah Pringle; Kornelis S M van der Geest; Wayel H Abdulahad; Maria Sandovici; Elisabeth Brouwer; Peter Heeringa; Annemieke M H Boots
Journal:  Arthritis Rheumatol       Date:  2021-11-01       Impact factor: 15.483

10.  Unique IL-13Rα2/STAT3 mediated IL-13 regulation detected in lung conventional dendritic cells, 24 h post viral vector vaccination.

Authors:  Sreeja Roy; Ho-Ying Liu; Muhammad Irwan Jaeson; Lachlan Paul Deimel; Charani Ranasinghe
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.